AG
GBT
Artal Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-350,000
| Closed | -$17M | – | 103 |
|
|
2019
Q3 | $17M | Buy |
+350,000
| New | +$17M | 0.68% | 23 |
|
|
2018
Q3 | – | Sell |
-200,000
| Closed | -$9.04M | – | 109 |
|
|
2018
Q2 | $9.04M | Hold |
200,000
| – | – | 0.19% | 32 |
|
|
2018
Q1 | $9.66M | Sell |
200,000
-150,000
| -43% | -$7.25M | 0.12% | 26 |
|
|
2017
Q4 | $13.8M | Buy |
350,000
+50,000
| +17% | +$1.97M | 0.21% | 17 |
|
|
2017
Q3 | $9.32M | Buy |
300,000
+200,000
| +200% | +$6.21M | 0.16% | 25 |
|
|
2017
Q2 | $2.74M | Sell |
100,000
-75,000
| -43% | -$2.05M | 0.05% | 59 |
|
|
2017
Q1 | $6.45M | Sell |
175,000
-71,054
| -29% | -$2.62M | 0.14% | 34 |
|
|
2016
Q4 | $3.56M | Buy |
246,054
+146,054
| +146% | +$2.11M | 0.08% | 37 |
|
|
2016
Q3 | $2.31M | Sell |
100,000
-25,000
| -20% | -$576K | 0.05% | 55 |
|
|
2016
Q2 | $2.07M | Buy |
+125,000
| New | +$2.07M | 0.04% | 42 |
|